Bank of New York Mellon’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.33M Sell
363,784
-14,218
-4% -$52K ﹤0.01% 2945
2025
Q1
$1.63M Sell
378,002
-40,818
-10% -$176K ﹤0.01% 2773
2024
Q4
$1.34M Buy
418,820
+109,762
+36% +$351K ﹤0.01% 2951
2024
Q3
$884K Sell
309,058
-84,740
-22% -$242K ﹤0.01% 3202
2024
Q2
$1.1M Buy
393,798
+33,990
+9% +$95.2K ﹤0.01% 3134
2024
Q1
$1.02M Sell
359,808
-858
-0.2% -$2.44K ﹤0.01% 3133
2023
Q4
$1.48M Sell
360,666
-135,063
-27% -$552K ﹤0.01% 2974
2023
Q3
$1.58M Buy
495,729
+7,432
+2% +$23.6K ﹤0.01% 2934
2023
Q2
$1.62M Buy
488,297
+13,302
+3% +$44.2K ﹤0.01% 2947
2023
Q1
$1.01M Sell
474,995
-359,859
-43% -$766K ﹤0.01% 3123
2022
Q4
$2.25M Buy
834,854
+152,253
+22% +$410K ﹤0.01% 2800
2022
Q3
$2.21M Buy
682,601
+60,525
+10% +$196K ﹤0.01% 2780
2022
Q2
$3.04M Sell
622,076
-14,928
-2% -$72.9K ﹤0.01% 2597
2022
Q1
$4.85M Buy
637,004
+70,447
+12% +$537K ﹤0.01% 2448
2021
Q4
$5.23M Buy
566,557
+58,222
+11% +$538K ﹤0.01% 2446
2021
Q3
$7.24M Buy
508,335
+92,690
+22% +$1.32M ﹤0.01% 2302
2021
Q2
$6.91M Buy
415,645
+263,566
+173% +$4.38M ﹤0.01% 2336
2021
Q1
$2.77M Buy
152,079
+55,049
+57% +$1M ﹤0.01% 2737
2020
Q4
$731K Buy
97,030
+41,125
+74% +$310K ﹤0.01% 3430
2020
Q3
$215K Buy
55,905
+567
+1% +$2.18K ﹤0.01% 3822
2020
Q2
$213K Buy
55,338
+26,963
+95% +$104K ﹤0.01% 3781
2020
Q1
$91K Buy
28,375
+2,135
+8% +$6.85K ﹤0.01% 3869
2019
Q4
$126K Hold
26,240
﹤0.01% 3987
2019
Q3
$173K Sell
26,240
-1,305
-5% -$8.6K ﹤0.01% 3919
2019
Q2
$210K Buy
+27,545
New +$210K ﹤0.01% 3900